Investor Relations

Advanced therapies for the sports medicine and severe burn care markets

Investor Relations

SEC Filings

SEC Filings

Filing date Form Description View
10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

View HTML
PRER14A

Proxy soliciting materials. Revised preliminary material

View HTML
S-2/A

Pre-effective amendment to S-2 filing

View HTML
S-3/A

Pre-effective amendment to an S-3 filing

View HTML
S-3/A

Pre-effective amendment to an S-3 filing

View HTML
S-3/A

Pre-effective amendment to an S-3 filing

View HTML
S-3/A

Pre-effective amendment to an S-3 filing

View HTML
S-3/A

Pre-effective amendment to an S-3 filing

View HTML
S-3/A

Pre-effective amendment to an S-3 filing

View HTML
S-3/A

Pre-effective amendment to an S-3 filing

View HTML
S-3/A

Pre-effective amendment to an S-3 filing

View HTML
S-3/A

Pre-effective amendment to an S-3 filing

View HTML
S-3/A

Pre-effective amendment to an S-3 filing

View HTML
POS AM

Post-effective amendment to an S-Type filing

View HTML

Data provided by Kaleidoscope.

Day High:
Day Low:
Volume:
on
Data Provided by Refinitiv. Minimum 15 minutes delayed.